Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.
Martin Lund KårhusAndreas BrøndenJulie Lyng FormanAnne HaaberTina VilsbøllDavid Peick SonneFilip K Krag KnopPublished in: BMJ open (2021)
EudraCA: 2018-003575-34; Pre-results.